期刊文献+

HPV感染、p16蛋白表达与宫颈病变关系的研究 被引量:1

下载PDF
导出
摘要 目的为了探讨HPV、p16与宫颈病变的关系。方法选择各级别宫颈病变患者130例,采用核酸分子快速导流杂交基因芯片分型技术(HybriMax)及免疫组织化学染色对所有患者分别进行宫颈脱落细胞标本HPV分型检测及病理活检或手术标本p16蛋白染色,分析HPV感染、p16蛋白表达与各级别宫颈病变的关系。结果①130例宫颈病变中检出15种常见的HPV亚型(检出率为71.4%),从高到低前5种依次为HPV16(56.15%)、HPV33(10.00%)、HPV18(6.92%)、HPV58(5.38%)、HPV31(3.85%)。②高危-HPV阳性率在浸润癌、CIN各组明显高于宫颈炎组,差异均有统计学意义(P<0.01)。③p16在CINⅡ/Ⅲ和宫颈浸润癌各组中为过表达(中、强阳性表达),在CINⅠ和正常组为阴性或弱阳性表达,阳性表达率在CINⅡ/Ⅲ和浸润癌组明显高于CINⅠ和宫颈炎组,差异均有统计学意义(P<0.01)。④HPV-16感染与p16表达呈密切相关r=0.998,P<0.01。结论宫颈病变与HPV感染密切相关,HPV16与宫颈癌关系最密切;p16免疫染色可以区分低、高度CIN。
出处 《中国医药指南》 2011年第16期128-130,共3页 Guide of China Medicine
  • 相关文献

参考文献12

  • 1Tavassoli FA,Davilee P.WHO classification of tumor.Pathology & genetics tumors of the breast and female genital organs[M].Lyon: ARC Press,2003:266.
  • 2Cox JT.Human papillomavirus testing in primary cervical screening and abnormal papanicolaou management[J].Chstet Gynecol Surv, 2006,61 (6): 15-25.
  • 3Kamb A,Cruis NA,Weaver-Feldnaus J,et al.A cell cycle regulator potentially involvoed in genesis of many tumor types[J].Science, 1994,264(5157):436-440.
  • 4H Zur Hausen.Viruses in human cancers[J].Science,1991,254 (5035): 1167-1173.
  • 5O'Connor DM.The Use of p16 as a marker for cervical cancer precursor lesions[J].J Lower Genital Tract Disease,2007,11(2): 67-68.
  • 6Kalof A,Cooper K.p 16INK4a immunoexpression: surrogate marker of high-risk HPV and high-grade cervical intraepithelial neoplasia [J].Adv Anat Pathol,2006,13 (4): 190-194.
  • 7Klaes R,Benner A,Friedrich T, et al.p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia[J].Am J Surg Pathol,2002,26(11): 1389- 1399.
  • 8Sayed K,Korourian S,Ellison D A,et al.Diagnosing cervical biopsies in adolescents: the use of p16 immunohistochemistry to improve reliability and reproducibility[J].J Lower Genital Tract Disease, 2007,11(3):141-146.
  • 9Sano T,Oyama T, Kashiwabara K,et al.Immunohistochemical overexpression of p 16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia[J].Pathol Int, 1998,48(8):580-585.
  • 10Murphy N,Ring M,Killalea AG,et al.p16INK4A as a marker for cervical dyskaryosis:CIN and cGIN in cervical biopsies and ThinPrep smears[J].J Clin Pathol,2003,56(1):56-63.

同被引文献18

  • 1罗建湘,吕文玲,谢聪莉,冯雪萍.宫颈上皮内瘤病及宫颈癌与HPV感染关系的探讨[J].实用预防医学,2007,14(1):75-77. 被引量:10
  • 2何桂蓉,刘忠.高危型HPV型别、病毒载量与宫颈癌前病变的相关性研究[J].现代检验医学杂志,2007,22(4):32-35. 被引量:22
  • 3Vernon SD,Unger ER,Reeves WC.Human papillomavirus and cer-vival cancer[J].Curr Prob Obstet Gynecol Fertil,1998,2(4):104.
  • 4Zur Hausen H,Meinhof W,Scheiber W,et al.Attempts to detectvirus-specific DNA sequence in human tumors:nucleic acid hybridiza-tion with complementary RNA of human wart virus[J].In.
  • 5Muz N,Bosch FX,de Sanjose S,et al.Epidemiologic classification ofhuman papillomavirus types associated with cervical cancer[J].N EnglJ Med,2003,348:518-527.
  • 6Czegledy J,Veress G,Konya J,et al.Genital human papillomavirus(HPV)infection in Hungarian women[J].Acta Microbiologica Hun-garica,1993,40(2):115-122.
  • 7Kruse AJ,Skaland I,Janssen EA,et al.Quantitative molecular param-eters to identify low-risk and high-risk early CIN lesions:role ofmarkers of proliferative activity and different.
  • 8Katase K,Teshima H,Hirai Y,et al.Natural history of cervical humanpapillomavirus lesions[J].Intervirology,1995,38(3-4):192-194.
  • 9Munger K,Yee CL,Phelps WC,et al.Biochemical and biological differ-ences between E7 oncoproteins of the high-and low-risk human pa-pillomavirus types are determined by amino-termi.
  • 10Chen LP,Thomas E K,Hu SL,et al.Human papillomavirus type16necleoprotein E7 is a tumor rejection antigen[J].Proc Natl Acad SciUSA,1991,88:110-114.

引证文献1

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部